The Add-Aspirin trial office is now fully back up and running following the power outage over Easter, apologies for any inconvenience caused.
All sites who have returned the required amendment documentation should now have received a 'green light' activation email and should work to Add-Aspirin Protocol v5.0 and associated documents.
New version CRFs can be downloaded from the members area and should be used for new and existing patients after 28th April 2017.
Please note, CRF version number does not correspond to protocol version number.
Participants consented for registration prior to implementation of the amendment on Consent Form v4 should be consented for randomisation on the same form, and no re-consent is required.
Contact Details
If you are an individual who is interested in taking part in Add-Aspirin, please talk to your doctor who will be able to consider whether you are suitable for the trial.
For healthcare professionals
Please log into the members area for Add-Aspirin contact details.
Register Interest
For healthcare professionals
If your centre would like to recruit participants to Add-Aspirin, contact us:
mrcctu.add-aspirin@ucl.ac.uk
From Monday 16th March 2020, to RANDOMISE a participant in the UK please call +44 (0)20 7670 4925, rather than the usual randomisation line.
To RANDOMISE a participant from Republic of Ireland or India only, please use the 'Register a participant' link above to randomise online. Please make sure to press 'Randomise' once logged in to the server.
Unblind a participant in the UK